Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues

Cairo University40 enrolled

Overview

additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated

hypthyroidism elder females (n=40) with glaucoma and fatty liver issues will randomly divided into group number 1 (n=20) that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month or group number II (n=20) that will receive levothyroxine only

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Subclinical hypothyroïdism Non-Alcoholic Fatty Liver Disease Primary Open Angle Glaucoma

Interventions

physical activityBEHAVIORAL

hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month

usual careOTHER

hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine only

Eligibility

Sex: FEMALEMin age: 65 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * subclinical hypothrodism (significant form) * primary opened angle gaulcoma in both eyes with ocular hypertension in both eyes )(high-tension typed glaucoma) * fatty liver (non alcholic type) * elder females Exclusion Criteria: * respiratory issues * cardiac issues * renal issues

Locations (1)

Cairo University

Dokki, Giza Governorate, Egypt

RECRUITING

Outcomes

Primary Outcomes

intraocular pressure

it will be assessed in both eyes

Time frame: 6 months

Secondary Outcomes

body mass index

it will be assessed on empty stomach and bladder

Time frame: 6 months

waist circumfrence

it will be assessed by tape at umblical level

Time frame: 6 months

systolic blood pressure

it will be assessed by sphygmomanmometer

Time frame: 6 months

diastolic blood pressure

it will be assessed by sphygmomanmometer

Time frame: 6 months

glaucoma assocaited life quality survey

it is a questionaire evaluates life quality

Time frame: 6 months

triglyceridss

it will be assessed in serum

Time frame: 6 months

high density lipoproteines

it will be assesed in serum

Time frame: 6 months

alanine transamianses

it will be assessed in serum

Time frame: 6 months

aspartate trasnamiansses

Central Contacts

Ali MA Ismail, lecturer

CONTACT

01005154209 ali.mohamed@pt.cu.edu.eg

fatma M Ali

CONTACT

01031321109 fatma1995@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.